Annual ROE:
-25.17%+7.81%(+23.68%)Summary
- As of today, TXG annual return on equity is -25.17%, with the most recent change of +7.81% (+23.68%) on December 31, 2024.
- During the last 3 years, TXG annual ROE has fallen by -17.69% (-236.50%).
- TXG annual ROE is now -149.23% below its all-time high of 51.13%, reached on December 31, 2018.
Performance
TXG ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-10.32%+1.31%(+11.26%)Summary
- As of today, TXG quarterly return on equity is -10.32%, with the most recent change of +1.31% (+11.26%) on September 30, 2025.
- Over the past year, TXG quarterly ROE has increased by +14.67% (+58.70%).
- TXG quarterly ROE is now -120.18% below its all-time high of 51.13%, reached on December 31, 2018.
Performance
TXG Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TXG ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +23.7% | +58.7% |
| 3Y3 Years | -236.5% | +50.8% |
| 5Y5 Years | +19.4% | +62.1% |
TXG ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -236.5% | +23.7% | at high | +70.3% |
| 5Y | 5-Year | -236.5% | +73.1% | -38.0% | +89.4% |
| All-Time | All-Time | -149.2% | +73.1% | -120.2% | +92.5% |
TXG ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -10.32%(+11.3%) |
| Jun 2025 | - | -11.63%(+46.9%) |
| Mar 2025 | - | -21.92%(+13.2%) |
| Dec 2024 | -25.17%(+23.7%) | -25.25%(-1.0%) |
| Sep 2024 | - | -24.99%(+22.4%) |
| Jun 2024 | - | -32.21%(+7.4%) |
| Mar 2024 | - | -34.77%(-6.0%) |
| Dec 2023 | -32.98%(-61.3%) | -32.81%(-15.2%) |
| Sep 2023 | - | -28.47%(-30.9%) |
| Jun 2023 | - | -21.75%(+0.8%) |
| Mar 2023 | - | -21.93%(-5.4%) |
| Dec 2022 | -20.45%(-173.4%) | -20.81%(+0.9%) |
| Sep 2022 | - | -20.99%(-17.7%) |
| Jun 2022 | - | -17.84%(-58.7%) |
| Mar 2022 | - | -11.24%(-50.3%) |
| Dec 2021 | -7.48% | -7.48%(+87.2%) |
| Sep 2021 | - | -58.36%(+19.1%) |
| Jun 2021 | - | -72.16%(+15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -85.52%(+12.2%) |
| Dec 2020 | -93.64%(-199.7%) | -97.45%(-258.0%) |
| Sep 2020 | - | -27.22%(+1.4%) |
| Jun 2020 | - | -27.60%(-44.7%) |
| Mar 2020 | - | -19.07%(+40.0%) |
| Dec 2019 | -31.24%(-161.1%) | -31.76%(+77.0%) |
| Sep 2019 | - | -137.91%(-3510.2%) |
| Jun 2019 | - | -3.82%(-108.4%) |
| Mar 2019 | - | 45.65%(-10.7%) |
| Dec 2018 | 51.13%(+206.5%) | 51.13%(+39.8%) |
| Sep 2018 | - | 36.57%(+2979.5%) |
| Jun 2018 | - | -1.27%(-42.7%) |
| Mar 2018 | - | -0.89%(-64.8%) |
| Dec 2017 | 16.68% | - |
| Dec 2017 | - | -0.54%(-68.8%) |
| Sep 2017 | - | -0.32%(-39.1%) |
| Jun 2017 | - | -0.23%(-53.3%) |
| Mar 2017 | - | -0.15% |
FAQ
- What is 10x Genomics, Inc. annual return on equity?
- What is the all-time high annual ROE for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. annual ROE year-on-year change?
- What is 10x Genomics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. quarterly ROE year-on-year change?
What is 10x Genomics, Inc. annual return on equity?
The current annual ROE of TXG is -25.17%
What is the all-time high annual ROE for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high annual return on equity is 51.13%
What is 10x Genomics, Inc. annual ROE year-on-year change?
Over the past year, TXG annual return on equity has changed by +7.81% (+23.68%)
What is 10x Genomics, Inc. quarterly return on equity?
The current quarterly ROE of TXG is -10.32%
What is the all-time high quarterly ROE for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high quarterly return on equity is 51.13%
What is 10x Genomics, Inc. quarterly ROE year-on-year change?
Over the past year, TXG quarterly return on equity has changed by +14.67% (+58.70%)